Correction to: Weight Reduction and Pioglitazone are Cost-Effective for the Treatment of Non-alcoholic Fatty Liver Disease in Thailand (PharmacoEconomics, (2019), 37, 2, (267-278),...

by Bunchai Chongmelaxme, Pochamana Phisalprapa, Ratree Manthaisong, Piyameth Dilokthornsakul, Nathorn Chaiyakunapruk
Published 2020